Why I'm Not Arbing The Fresenius / Akorn Deal | Latest News RSS feed

Why I'm Not Arbing The Fresenius / Akorn Deal - Latest News


Why I'm Not Arbing The Fresenius / Akorn Deal

I am not interested in risk-arbing this deal at the current risk/reward profile (6.25% in 1 year). The deal continues to make sense from a strategic perspective for Fresenius, but I think Akorn has si... read more

Corruption Currents: Trump Asserts ‘Absolute Immunity’ in Emoluments Lawsuit

(AM ... if she is not indicted on charges of misusing government funds. (Haaretz) Court documents made public this week show Germany-based healthcare company Fresenius Medical Care & Co. said it found ... read more

Why Akorn Shares Were Halved

Delaware’s Vice Chancellor Travis Laster noted that Fresenius validly terminated the merger agreement and he found Akorn’s representations regarding its compliance with regulatory requirements were “n... read more

Looking for another news?


Akorn was warned about problems that scotched $4.3B Fresenius deal, exec testifies

Fresenius officials contend manufacturing problems at the Decatur plant and others, along with Akorn's submission of allegedly phony data to federal regulators, are justifications for nixing the $34-p... read more


Akorn Craters 32% On FDA Probe - Time To Buy?

The company announces a probe by Acquirer Fresenius amid FDA allegations. Akorn says it sees no material issues and the deal should ... so I am likely a daytrader in the name looking for some bounce-b... read more

Akorn fights back as European drug company retreats from $4.3 billion takeover

The acquisition has been in the works since April 2017, when both companies said they hoped to close the deal early this year. Both boards approved the agreement, under which Fresenius would acquire A... read more

Why Diana Shipping, Akorn, and Granite Construction Jumped Today

But if JPMorgan is right, then a greater level of confidence in the shipping industry could lead to further gains not just for ... Already, Fresenius has made some strategic purchases within Europe, b... read more

GE, Tesla and GM jump while Akorn plunges

Akorn Inc., down $7.62 to $5.36 A court ruled against Akorn and said German health care company Fresenius can back out of its deal to buy it. read more

Could Data Breaches Break Up the Akorn Aquisition?

This isn’t the first time that Akorn has faced concerns regarding its security, but this could be the costliest. Essentially, Fresenius is conducting an independent investigation into “alleged breache... read more

HO UK Home Office : UK government publishes proposals on rights of EU citizens

That is why I initially sought an agreement on this before we triggered Article 50. And it is why I am making it an immediate priority at ... Those who arrived before the specified date but do not yet ... read more

Big pharma eyes takeover of Claris’ injectables business for Rs 2500-Rs 3000 crore

The recent Pfizer-Hospira deal, as per industry ... Infact, in 2012, Akorn acquired certain injectable assets of Indian CMO Kilitch Drugs. Analysts add, among the buyers, the maximum strategic value w... read more

Akorn, Chamber celebrate West Grand Avenue expansion

DECATUR — Akorn and Decatur business leaders on Tuesday celebrated the opening of a $25 million expansion on West Grand Avenue with a ribbon-cutting ceremony. The company announced the 60,000-square f... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us